None listed
Conditions
Brief summary
This study represents an examination of a novel iCBT-based self-management program for people who use methamphetamine, ‘IMPACT’. The primary objective of the study is to examine the feasibility of the IMPACT program. Feasibility is defined as uptake, acceptability (participant satisfaction, perceived usefulness, and ease-of-use), participant safety, completion rates, and drop-out. The secondary objective of the study is to examine pre-post changes in methamphetamine use and psychological wellbeing, assessed via validated self-report measures. There is a clear need for further exploration of the feasibility and potential clinical utility of digital health interventions specifically for people who use methamphetamine; and whether a product tailored for people who use methamphetamine - such as the IMPACT program - will lead to better engagement and ultimately improved outcomes.
Interventions
The intervention is a six-week web-based self-management program called IMPACT, designed to help individuals change their relationship with methamphetamine. The program is grounded in cognitive behavioural therapy (CBT) and includes one pre-lesson and five weekly modules delivered sequentially via a secure online platform. Each module introduces and builds upon core CBT strategies including motivational enhancement, behavioural activation, cognitive restructuring, and relapse prevention. Content includes psychoeducation, interactive activities, downloadable worksheets, and animated videos tailored to methamphetamine use. Intervention adherence will be monitored through the collection of website analytics and module completion data. Each module will take approximately 30 minutes each day or 3.5 hours total to complete. The program is self-guided and fully automated. Participants receive email prompts to begin each module and reminders if they do not engage. No clinician involvement is included. A bonus module on sleep hygiene is made available after the main program but is not part of the intervention being formally evaluated. Feasibility outcomes (including uptake, engagement, safety, and acceptability) and clinical outcomes (e.g. methamphetamine use, cravings, psychological distress) are measured through validated online self-report questionnaires administered at baseline and at six-week follow-up. Qualitative interviews with a subset of participants will further explore feasibility and acceptability.
Sponsors
Study design
Eligibility
Inclusion criteria
Participants are eligible to participate in this study if they: Are aged 18 or older, Used methamphetamine at least once in the last month, Currently reside in Australia, Have access to a computer with internet access, and Are willing to provide informed consent.
Exclusion criteria
Participants not meeting all of the inclusion criteria are not eligible to participate. There are no additional exclusion criteria.